Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2020-09-28
2021-03-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Efficacy of Local Infiltration Analgesia for Postoperative Pain Management After Total Knee Arthroplasty
NCT04258241
Function and Pain Following Knee Replacement
NCT05478005
Analgesic Value of Adductor Canal vs Femoral Block After Total Knee Arthroplasty
NCT03395990
Effects of Ischemic Preconditioning on Conditioned Pain Modulation and Heart Rate Variability in Knee Osteoarthritis
NCT05059652
Heat Application to Quadriceps Effect on Pain After a Total Knee Arthroplasty
NCT05462483
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Methods: In this study we are going to recruit 169 participants to compare them in two groups. group-1 iPACK (n=85) will receive Adductor Canal Block (ACB) + iPACK and group 2 LIA (n=84) ACB+ periarticular Local Infiltration Analgesia (LIA). All participants, care provider (nurses \& assistant anesthetists) and outcome assessors (physiotherapist) will be blinded to the group allocation. Only the anesthesiologist responsible for perioperative care performing the ACB and iPACK blocks will be aware of the randomization. All peripheral nerve blocks will be performed with complete aseptic technique and under ultrasound guidance. Periarticular LIA will be performed by the surgeon with the landmark technique base. This study will be conducted in six months' duration. All patients will consent for spinal anesthesia, ACB, and iPACK and they will be instructed how to report pain on a 10 cm long Numerical Rating Scale (NRS) postoperatively.
The primary outcome, severity of pain (NRS) will be evaluated in Post Anesthesia Care Unit (PACU). The secondary outcome, time to mobilization along with pain score will be recorded in the ward after 2 hours of surgery then every 12 hours until the patient discharged home. Quadriceps muscle strength will be evaluated with the knee range of motion (ROM). A completely straight knee joint (extension) will measure 0° and a fully bent knee will have a flexion of at 130° degrees. The Timed-Up-and-Go (TUG) tests to evaluate functional recovery after TKA. The TUG test measures the time it takes a patient to get up from a chair, walk 3 m, and return to the sitting position in the chair.
On arrival to operation room (OR), all eligible participants will have intravenous (IV) cannula in situ and monitors according to the Association of Anesthetists of Great Britain and Ireland (AAGBI). Under complete aseptic technique, spinal anesthesia will be performed with pencil point 25 Gauge (Whitacre) needle with heavy Bupivacaine 0.5% and Fentanyl 15 micrograms (mics) total 3 milliliters (ml). After spinal anesthesia, each participant will receive either ultrasound-guided ACB+iPACK or ACB+ periarticular LIA.
Description of peripheral nerve blocks technique:
Adductor Canal Block (ACB): The skin is disinfected and the transducer (SonoSite 8-14 MHz) is placed anteromedially, approximately at the junction between the middle and distal third of the thigh. The saphenous nerve is usually identified as anterior and lateral to the femoral artery. The needle (Pajunk Germany100 mm) will be inserted in-plane from lateral-to-medial orientation and advanced toward the femoral artery deep to the sartorius muscle. Once the needle tip is visualized anterior to the artery and after careful aspiration, 1-2 mL of local anesthetic will be injected to confirm the proper injection site. If injection of local anesthetic does not appear to result in its spread around the femoral artery, additional needle repositions and injections may be necessary. A total of 20 millilitres (ml) of Bupivacaine 0.25% will be injected.
Interspace between the popliteal artery and the capsule of the posterior knee (iPACK):
The patient will be placed in a supine position with the lower extremity flexed at the knee and abducted at the hip. To begin scanning, the transducer will be placed on the lower third of the medial thigh to visualize the femur and the femoral vessels in cross-section. The transducer then will be slide caudally to observe the femoral artery as it dives into the popliteal fossa through the adductor hiatus to become the popliteal artery. At this point, the transducer will be moved posteriorly and inferiorly to visualize the space between the popliteal artery and the shaft of the femur just superior to the femoral condyles. The needle will be inserted, in a plane, from the anterior end of the transducer in a medial to the lateral trajectory, keeping the needle parallel to the acoustic shadow of the femur. With the needle tip resting 2 cm beyond the lateral border of the artery, 20 mL of Bupivacaine 0.25% will be injected, after negative aspiration of blood, to infiltrate the tissue space in divided doses as the needle is withdrawn.
Periarticular Local Infiltration Analgesia (LIA):
A mixture of Bupivacaine 0.25% 20 ml + epinephrine 100 mics ± lornoxicam 8 mg ± morphine 10 mg ± tranexamic acid 1 gm in 40 ml normal saline (NS) will be injected into the posterior capsule and the medial and lateral ligaments just before implantation: after insertion of the implants and into the capsule and retinacular tissues. The remaining solution (approximately 20 mL) will be used to infiltrate the muscle and subcutaneous tissues.
Postoperatively all participants will be prescribed 1 gm Paracetamol oral every 6 hours + buprenorphine transdermal patch 5 mics ± celecoxib 200 mg every 12 hours ± oxycodone 10 mg every 12 hours ± pregabalin 75 mg every 12 hours for breakthrough pain.
Sample Size:
In King Khalid University Hospital, we are approximately doing annually 300 TKA cases. Assuming that and confidence level of 95%, margin of error 5% Raosoft® recommended sample size is 169.
Data Collection:
The data will be collected by the outcome assessors who will be unaware of group allocation and will record their findings in patient's file and on predesigned form. Patients demographic data, duration of surgery, tourniquet time, PACU stay, postoperative heart rate, mean arterial pressure, pain score, knee range of motion (ROM), time-up-go (TUG), time to hospital discharge, patient and surgeon satisfaction and any complication will be recorded.
Statistical Analysis:
Statistical analysis was performed using Statistical Package for the Social Sciences (SPSS) version 24.0 software (SPSS Inc., Chicago, IL, USA).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
iPACK
In this group, participants will receive a peripheral nerve anesthetic block that is iPACK (Interspace between the Popliteal Artery and the Capsule of the posterior Knee) to cover posterior knee pain after total knee arthroplasty (TKA). This anesthetic block will be performed by assigned anesthesiologist under ultrasound guidance.
iPACK
Interspace between the popliteal artery and the capsule of the posterior knee (iPACK):
This is basically ultrasound guided peripheral nerve block performed by the anesthesiologists at the posterior side of the knee to control pain after TKA.
Periarticular local infiltration analgesia (LIA)
In this group, participants will receive a mixture of bupivacaine 0.25% 20 ml + epinephrine 100 mics ± lornoxicam 8 mg ± morphine 10 mg ± tranexamic acid 1 gm in 40 ml normal saline (NS) that will be injected into the posterior capsule and the medial and lateral ligaments just before implantation: after insertion of the implants and into the capsule and retinacular tissues. The remaining solution (approximately 20 mL) will be used to infiltrate the muscle and subcutaneous tissues. This local anesthetic infiltration is commonly performed by the operating orthopedic surgeon during TKA for postoperative pain control.
Periarticular local infiltration analgesia (LIA)
A mixture of Bupivacaine 0.25% 20 ml + epinephrine 100 mics ± lornoxicam 8 mg ± morphine 10 mg ± tranexamic acid 1 gm in 40 ml normal saline (NS) will be injected into the posterior capsule and the medial and lateral ligaments just before implantation: after insertion of the implants and into the capsule and retinacular tissues. The remaining solution (approximately 20 mL) will be used to infiltrate the muscle and subcutaneous tissues. This intervention is commonly performed by the operating orthopedic surgeon to control pain after TKA.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
iPACK
Interspace between the popliteal artery and the capsule of the posterior knee (iPACK):
This is basically ultrasound guided peripheral nerve block performed by the anesthesiologists at the posterior side of the knee to control pain after TKA.
Periarticular local infiltration analgesia (LIA)
A mixture of Bupivacaine 0.25% 20 ml + epinephrine 100 mics ± lornoxicam 8 mg ± morphine 10 mg ± tranexamic acid 1 gm in 40 ml normal saline (NS) will be injected into the posterior capsule and the medial and lateral ligaments just before implantation: after insertion of the implants and into the capsule and retinacular tissues. The remaining solution (approximately 20 mL) will be used to infiltrate the muscle and subcutaneous tissues. This intervention is commonly performed by the operating orthopedic surgeon to control pain after TKA.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Scheduled for elective unilateral TKA
* Age \> 18 \< 80 years
* BMI \< 40 kg/m2
Exclusion Criteria
* Patient scheduled for revision of TKA
* Rheumatoid Arthritis patient
* Prior back surgery
* Patients on any anticoagulant
* Any other contra-indication for spinal anesthesia
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
King Khalid University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Abdul Sattar Narejo
Consultant Anesthesiologist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Abdul Sattar Narejo, FCPS, FCAI
Role: PRINCIPAL_INVESTIGATOR
King Saud University College of Medicine and King Khalid University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
King Khalid University Hospital
Riyadh, , Saudi Arabia
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
YaDeau JT, Cahill JB, Zawadsky MW, Sharrock NE, Bottner F, Morelli CM, Kahn RL, Sculco TP. The effects of femoral nerve blockade in conjunction with epidural analgesia after total knee arthroplasty. Anesth Analg. 2005 Sep;101(3):891-895. doi: 10.1213/01.ANE.0000159150.79908.21.
Fine PG. Long-term consequences of chronic pain: mounting evidence for pain as a neurological disease and parallels with other chronic disease states. Pain Med. 2011 Jul;12(7):996-1004. doi: 10.1111/j.1526-4637.2011.01187.x.
Runge C, Borglum J, Jensen JM, Kobborg T, Pedersen A, Sandberg J, Mikkelsen LR, Vase M, Bendtsen TF. The Analgesic Effect of Obturator Nerve Block Added to a Femoral Triangle Block After Total Knee Arthroplasty: A Randomized Controlled Trial. Reg Anesth Pain Med. 2016 Jul-Aug;41(4):445-51. doi: 10.1097/AAP.0000000000000406.
Kwofie MK, Shastri UD, Gadsden JC, Sinha SK, Abrams JH, Xu D, Salviz EA. The effects of ultrasound-guided adductor canal block versus femoral nerve block on quadriceps strength and fall risk: a blinded, randomized trial of volunteers. Reg Anesth Pain Med. 2013 Jul-Aug;38(4):321-5. doi: 10.1097/AAP.0b013e318295df80.
Jiang X, Wang QQ, Wu CA, Tian W. Analgesic Efficacy of Adductor Canal Block in Total Knee Arthroplasty: A Meta-analysis and Systematic Review. Orthop Surg. 2016 Aug;8(3):294-300. doi: 10.1111/os.12268.
Grevstad U, Mathiesen O, Valentiner LS, Jaeger P, Hilsted KL, Dahl JB. Effect of adductor canal block versus femoral nerve block on quadriceps strength, mobilization, and pain after total knee arthroplasty: a randomized, blinded study. Reg Anesth Pain Med. 2015 Jan-Feb;40(1):3-10. doi: 10.1097/AAP.0000000000000169.
Thobhani S, Scalercio L, Elliott CE, Nossaman BD, Thomas LC, Yuratich D, Bland K, Osteen K, Patterson ME. Novel Regional Techniques for Total Knee Arthroplasty Promote Reduced Hospital Length of Stay: An Analysis of 106 Patients. Ochsner J. 2017 Fall;17(3):233-238.
Related Links
Access external resources that provide additional context or updates about the study.
King Khalid University Hospital
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB PROJECT NO. E-20-4819
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.